Dietary Approaches for Management of Non-Alcoholic Fatty Liver Disease: A Clinician's Guide.
Aiya AboubakrAndrea StroudSonal KumarCarolyn NewberryPublished in: Current gastroenterology reports (2021)
Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity, insulin resistance, and hyperlipidemia. There is strong clinical evidence that reduction in at least 5-7% total body weight is associated with improvement in hepatic steatosis and regression of fibrosis, with weight loss representing the primary approach to treatment. This guide reviews recent data on dietary approaches studied in NAFLD management. The strongest evidence currently supports a hypocaloric diet to induce weight loss and subsequent improvement in liver enzymes and histology, as well as a Mediterranean diet, which can lead to improvement in steatosis even in the absence of weight reduction. The purpose of this paper is to provide clinicians with tools to engage patients in conversations about nutrition in the setting of NAFLD, ultimately guiding suitable personalized dietary recommendations.
Keyphrases
- weight loss
- insulin resistance
- bariatric surgery
- body weight
- roux en y gastric bypass
- high fat diet
- gastric bypass
- high fat diet induced
- end stage renal disease
- ejection fraction
- adipose tissue
- metabolic syndrome
- physical activity
- glycemic control
- weight gain
- liver fibrosis
- chronic kidney disease
- type diabetes
- obese patients
- skeletal muscle
- polycystic ovary syndrome
- palliative care
- patient reported outcomes
- big data
- combination therapy
- prognostic factors
- artificial intelligence
- meta analyses
- replacement therapy